Human Holdings Co (2415) Q3 2026 earnings summary

Executive summary

• Revenue/net sales increased 1.9% year-over-year to ¥76,384 million, with all segments contributing to growth.

• Operating profit declined by 2.7% to ¥2,186 million, mainly due to delayed recovery in the education segment.

• Ordinary profit rose 1.5% to ¥2,410 million, supported by non-operating income such as subsidies in the nursing care business.

• Net profit attributable to shareholders/owners of parent decreased by 2.4% to ¥1,415 million, impacted by the absence of prior year’s one-time gain from business transfer.

Financial highlights

• Revenue: ¥76,384 million (+1.9% YoY); Operating profit: ¥2,186 million (−2.7% YoY); Ordinary profit: ¥2,410 million (+1.5% YoY); Net profit: ¥1,415 million (−2.4% YoY).

• Gross profit rose to ¥19,443 million from ¥19,190 million YoY; SG&A expenses increased to ¥17,257 million.

• Earnings per share for the nine months was ¥136.38, down from ¥139.75 YoY.

• All major segments contributed to revenue growth, with notable increases in nursing care (+4.4%) and other businesses (+15.9%).

• Operating profit margin was 2.9%, down from 3.0% in the previous year.

Outlook and guidance

• No revision to full-year guidance; record-high revenue and profits expected for FY2026/3.

• Full-year revenue forecast: ¥103,600 million (+3.3% YoY); Operating profit: ¥3,600 million (+5.7% YoY); Ordinary profit: ¥3,700 million (+3.5% YoY); Net profit: ¥2,500 million (−4.1% YoY).

• Full-year earnings per share forecasted at ¥240.90; year-end dividend forecast at ¥72.50 per share.

• Progress toward plan is generally on track, though education segment recovery is slower than expected.